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Insertion-deletion polymorphism (InDeL) is the second most frequent type of genetic variation in the human genome. For
the detection of large InDeLs, researchers usually resort to either PCR gel analysis or RFLP, but these are time consuming
and dependent on human interpretation. Therefore, a more eﬃcient method for genotyping this kind of genetic variation is
needed. In this report, we describe a method that can detect large InDeLs by DHPLC (denaturating high-performance liquid
chromatography) using the angiotensin-converting enzyme (ACE) gene I/D polymorphism as a model. The InDeL targeted in this
study is characterized by a 288 bp Alu element insertion (I). We used DHPLC at nondenaturating conditions to analyze the PCR
product with a flow through the chromatographic column under two diﬀerent gradients based on the diﬀerences between D and
I sequences. The analysis described is quick and easy, making this technique a suitable and eﬃcient means for DHPLC users to
screen InDeLs in genetic epidemiological studies.
Copyright © 2008 Renata Guedes Koyama et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Insertion-deletion (InDel) polymorphisms are an important
and abundant form of human genome variation; they are
the second most frequent type of polymorphisms in the
human genome and may be observed at the level of single-
base pairs, multibase pair expansions of repeat units, random
DNA sequence insertions and deletions, and as transposon
insertions. This kind of DNA polymorphism can be used for
the purpose of genetic mapping and diagnostics [1].
It is well known that translocation insertions and gross
deletions (>100 pb) are important causes of both cancer
and inherited diseases. Microdeletions and microinsertions
(≤20 bp) account for 17% of all inherited diseases, as
reported in the May 2007 release of the human gene
mutation database (www.hgmd.org/).
An example of such polymorphism is the inser-
tion/deletion (I/D) in the angiotensin-converting enzyme
(ACE) gene that has been associated with many diseases,
particularly of the cardiovascular system. Reports of such
associations include risk of myocardial infarction and car-
diovascular disease, ischemic stroke, eﬀects on response of
human muscle to strength training [2–6], and hypertension
in subjects with mild to moderate degrees of sleep apnea (5 ≤
apnea-hypopnea index ≤ 30) [7].
In the renin-angiotensin system, ACE is a well-known
zinc metallopeptidase that is widely distributed on the
surface of endothelial and epithelial cells. ACE plays a role
in the conversion of the inactive decapeptide, angiotensin I
(Ang I or Ang 1–10), into the active octapepptide and potent
vasoconstrictor angiotensin II (Ang II or Ang 1–8) as well as
in the inactivation of the vasodilator bradykinin [8, 9].
The ACE InDel polymorphism is characterized by the
presence (insertion, I) or absence (deletion, D) of a 288 bp
DNA sequence in intron 16 of the gene. This insertion
sequence is an Alu element (three Alu-repeat).
Although several genetic studies of the ACE D allele have
associated polymorphism with cardiovascular disease, these
data are questionable due to probable mistyping of the ACE I
allele [10]. This problem occurs because of the diﬀerent sizes
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of I and D allele PCR products, which are 490 bp and 190 bp,
respectively. But it happens that the D (shorter) allele possess
the property of being preferentially amplified compared to
the I allele, and this diﬀerential response to amplification
may lead to mistyping of the ID sample.
Conflicting reports of ACE I/D frequencies have also
been described, given the diﬃcult nature of this geno-
typing. The diversity of findings has been attributed to
methodological and technical variations in detection of the
polymorphisms [11].
The first description of ACE I/D polymorphism genotyp-
ing proposed by Rigat et al. [12] was a PCR method using a
set of primers flanking the insertion. However, as mentioned
earlier, the D allele is preferentially amplified, so the ID
heterozygote can be mistyped as DD, thus causing a higher
frequency for this genotype. The probability of this mistyp-
ing has been estimated to be 5–10% [13, 14]. Therefore,
careful control is required and repeated testing is also often
necessary, especially when verifying the ID heterozygote.
This method has been modified several times, and a
confirmatory PCR has been proposed by Shanmugan et al.
[15] to minimize mistyping of the I allele as a D allele. In this
method, a new sense primer is used inside the Alu sequence,
resulting in amplification of a 408 bp fragment of allele I. The
D allele shows no amplification under this condition due to
lack of an annealing site for the new sense primer, so it works
as an additional amplification after the conventional method.
The authors reported 100% accuracy with this methodology.
However, use of a primer annealing inside an Alu sequence
may cause nonspecific annealing due to structural diﬀerences
in the I and D allele in which there are three Alu sequences.
Therefore, problems with preferential amplification by PCR
are not entirely excluded with this method [16]. Eight human
genes specific to Alu insertion polymorphisms have been
described (ACE, TPA25, PV92, APO, FXIIIB, D1, A25, and
B65) [17], and theoretically, any of them can be amplified
by PCR using a primer that anneals in the Alu sequence.
Moreover, this methodology generally involves various steps
and is time consuming.
Other modifications have included a step-down PCR,
as described by Chiang et al. [16], which aims to increase
the product and the detection rate of the I allele. This
method involves initial PCR annealing temperatures higher
than the melting point of the primers, followed by annealing
temperatures reduced stepwise to the melting point. In this
technique with high amplification failure, the results should
be interpreted by two diﬀerent observers, and consensus
opinions have to be obtained from a third observer blinded
to the results from the other two.
The low resolution of these methods can lead to dif-
ficulties in data interpretation, and also requires various
time-consuming steps. Therefore, a more eﬃcient means
of ACE genotyping is particularly desirable for clinical and
epidemiologic investigations. Other techniques have been
purposed, such as real-time PCR [18], to detect ACE ID
polymorphism, but this has not been used in genetic associ-
ation studies, likely because of the need for specific and more
expensive reagents. The multiplex approach, proposed by
Evans et al. [19], improves the accuracy of ACE genotyping,
but presents diﬃculties in the post-PCR handling, such
as agarose diagonal gel electrophoresis. Moreover, to our
knowledge, the multiplex approach is specific to ACE InDel
genotyping and cannot be extended to other systems.
Here, we report a protocol using DHPLC (denaturating
high-performance liquid chromatography) to genotype large
InDels employing the ACE gene I/D polymorphism as a
model. The major advantage of this method is the ease
it provides in screening a large number of samples while
avoiding electrophoresis and gel analysis.
The technique is based on automated detection of DNA
segments by ion-pair reverse-phase high performance liquid
chromatography [20]. This approach normally compares
two alleles after denaturing and reannealing PCR amplicons.
In this methodology, a preliminary quality analysis of the
amplicon is always done in nondenaturing conditions at
50◦C in order to quantify and verify the quality of the PCR
product. Under such nondenaturing conditions, the presence
of InDels in single-base pairs or small repeat units can be
detected [21–24]. This method does not work well, however,
in detecting large InDels (>50 pb) because the gradient flow
is designed for small (deletion) sequences [25].
In the present study, we chose to analyze the ampli-
con using the DHPLC instrument at a nondenaturating
temperature, using the same PCR product to flow through
the chromatography column under two diﬀerent gradients,
which were based on the predicted D and I allele sequences.
We compared this DHPLC method with the conventional
and confirmatory methods for ACE I/D polymorphism
genotyping, and we propose this methodology for genotyp-
ing InDels throughout the genome.
2. MATERIALS ANDMETHODS
2.1. Samples
Genomic DNA was directly extracted from 3 mL of whole
blood [26] from 335 volunteers with mixed ethnic back-
grounds, after obtaining their written informed consent.
2.2. Conventional PCR
Genotyping of the ACE gene was performed in all 335
samples, as described by Rigat et al. [12]. The primers anneal
outside the insertion/deletion region in intron 16 of the
ACE gene and yield a PCR product of 490 base pairs (bp)
in the case of the insertion allele or 190 bp in the case of
deletion allele. Depending on the presence or absence of the
insertion allele, the genotype of the subjects was classified as
II (homozygote for the insertion allele), DD (homozygote for
the deletion allele), or ID (heterozygote).
2.3. Confirmatory PCR
Each sample found to be of the DD genotype using the
conventional method was subjected to a second independent
PCR amplification with a set of primers that recognize the
Alu insertion-specific sequence, as described by Shanmugan
et al. [15]. A PCR product of 408 bp indicated the insertion
allele.
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CTGGAGACCACTCCCATCCTTTCTCCCATTTCTCTAGACCTGCTGCCTATATAC
AGTCACTTTTATGTGGTTTCGCCAATTTTATTCCAGCTCTGAAATTCTCTGAGCT
CCCCTTACAAGCAGAGGTGAGCTAAGGGCTGGAGCTCAAGGCATTCAAACCCCT
ACCAGATCTGACGAATGTGATGGCCACATC
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Figure 1: Observed chromatograms patterns in the DHPLC system
at 50◦C after submitting the same samples to the two conditions.
(a) ACE I sequence and chromatogram. (b) ACE D sequence and
chromatogram. The lines in the upper part of both chromatograms
show I/I genotype, the line in the middle is the D/D genotype, and
the line below is the I/D genotype. The homozygotes show a peak
when their sequences are analyzed, and the heterozygotes show a
peak in both analyses.
2.4. DHPLC analysis
DHPLC analysis was performed in each sample found to have
the DD genotype using the conventional method [12].
Genomic DNA samples were subjected to PCR using
10 mM of forward primer and 10 mM of reverse primer,
as described by Rigat et al. [12], in a solution containing
1.0 mM MgCl+2, 2.5 mM Tris-HCl (pH 9.0), 1.0 mM each
of dNTP, and 1 U of Platinum Taq DNA polymerase
(Invitrogen, SP, Brazil).
We entered the two predicted sequences, representing
the ACE gene I and D alleles (NCBI ref X62855, SNP:
rs13447447-Figure 1), into the system to create two diﬀerent
gradients of buﬀers and acetonitrile. The system control
software (Transgenomic Navigator Software version 1.5.4,
Transgenomic Inc., USA) gave the flow rate of the reagents
based on the predicted sequences. The reverse phase gradient
was performed under two diﬀerent conditions, one for each
allele. In condition 1, for the D sequence, the gradient was
initially set to 47.2% 0.1 M TEAA, pH 7.0 (buﬀer A) mixed
with 52.8% 0.1 M TEAA, pH 7.0, v/v 25% acetronitrile
(buﬀer B). At the end point (5 minutes), the gradient was
38.2% buﬀer A and 61.8% buﬀer B. The gradient used for
condition 2, for the large sequence (I), started with 39.2% of
buﬀer A mixed with 60.8% of buﬀer B, and at the end point
(5 minutes) the gradient was composed of 30.2% buﬀer A
and 69.8% buﬀer B.
Eight µL of PCR product was applied twice to a DNASep
column (Transgenomic-Wave 3500A DHPLC system, ref
DNA 99 3510, 4.6 mm × 50 mm, Transgenomic Inc., USA).
Elution of DNA was detected by 260 nm UV absorbance,
and the chromatograms were analyzed by the presence or
absence of amplicon at 50◦C with the two gradients and flows
(Figure 1).
3. RESULTS
From the initial 335 samples, 95 were found to be of the
DD genotype. These were reevaluated using the conventional
genotyping method, as well as the confirmatory and DHPLC
methods for comparison. We confirmed that 81.05% of the
95 samples were the DD genotype. However, in using the
DHPLC and confirmatory methods, 18.95% of the samples
proved to be the ID genotype. In two cases (2.1%) only the
DHPLC detected the ID genotype and in another two cases
(2.1%) only confirmatory PCR detected the ID genotype
(Table 1).
An example of the pattern found using the DHPLC
method is shown in Figure 1. The DD genotype was only
detected by the specific DHPLC gradient and flow designed
for the shorter PCR product (see Mat&Meth DHPLC
condition 1), and the II genotype was detected only by the
specific DHPLC gradient and flow designed for the larger
PCR product (see Mat&Meth DHPLC condition 2). When
we had heterozygosity (I/D genotype sample), we observed
peaks in the two diﬀerent gradient and flow conditions.
4. DISCUSSION
In this report, we established the use of DHPLC for rapid
screening of large InDels such as ACE I/D polymorphisms.
Compared to other genotyping techniques, DHPLC oﬀers
several technical advantages. In a large-scale genotyping
setting such as population screening, the adaptability of
DHPLC, along with its high throughput, should significantly
reduce overall processing time. Also, the autorun mode of
DHPLC significantly decreases handling time without the
loss of assay specificity [27–29], and screening is relatively
quick and easy (8 minutes for total run per sample after
PCR, including sample injection, column equilibration, and
cleaning).
The method presented here oﬀers several specific advan-
tages over the other methods used to genotype ACE I/D
polymorphisms, in which the false-positive mistyping of the
DD genotype is a concern. The probability of mistyping
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Table 1: Frequencies of DD only genotype using DHPLC and confirmatory methods.
Genotype % (n) Confirmatory % (n) DHPLC % (n)
DHPLC + Confirmatory % (n)
Concordances Diﬀerences
DD 100 (95) 81.05 (77) 81.05 (77) 78.95 (75) 2.11 (2)
ID 0 18.95 (18) 18.95 (18) 16.84 (16) 2.11 (2)
has been cited by some authors to range from 5–10%
[13, 14], but in our samples we detected a discrepancy
in 19% of cases. Certainly, this accuracy depends on the
observer’s expertise in performing PCR gel electrophoresis
analyses. The confirmatory PCR method, used to overcome
this problem, is time consuming since two PCRs must be
performed, and some believe that the results (the PCR bands
in the gel) should be assessed by more than one observer to
avoid misinterpretation [15]. This method has been reported
to have 100% accuracy in genotyping the ID heterozygote.
However, in our study, the ID heterozygote was not detected
in 2% of all samples. Chiang et al. [16] also showed decreased
detection of the I/D heterozygote using this method relative
to the step-down approach. DHPLC has the advantage
of genotyping many samples without supervision and the
DHPLC can run overnight with automatically generated
results. If the PCR conditions is carefully optimized and
the injected amplicon is unique and pure, the exit pattern
shows only one clear and recognizable peak, thus avoiding
the necessity of analysis by two independent observers.
DHPLC methodology makes genotyping of slightly mod-
ified DNA, like SNPs and small InDels (1 to 50 bp) feasible
for numerous samples and has been used in many studies
[30–32]. Traditionally, DHPLC has not been recommended
for large InDels, because the gradient flow is designed for one
sequence (deletion, e.g.), thus rendering the other (insertion)
unrecognizable [24, 25]. We observed this phenomenon
when we analyzed the ACE amplicon in a single DHPLC
run, but in this study we demonstrated that it is possible to
overcome this problem with two separate runs using diﬀerent
gradient flows for each allele. Therefore, DHPLC may be used
to detect large InDels (up to ∼200 bp) if one analyzes the
amplicon using two nondenaturating runs with two buﬀer
gradients and two flow adjustments.
To the best of our knowledge, this is the first report
of a DHPLC selective approach to genotyping large InDels
using two sequences input for two gradients of buﬀers and
two flow adjustments to analyze both sequences separately.
A multiplex-PCR coupled to HPLC analysis under nonde-
naturating conditions for detection of large InDels [33] has
already been proposed, but small nonspecific peaks might
hamper the analysis.
We have shown in this study that this DHPLC method
is highly eﬃcient and reproducible in the detection and
genotyping of the ACE ID polymorphism, which has been
a challenging goal to achieve. In our study, two cases with the
ID genotype were not detected by DHPLC but were detected
by confirmatory PCR. In another two cases, only DHPLC,
but not confirmatory PCR, detected the ID genotype. There
is no clear explanation for this, but we conclude that
identification of large InDels, like the ACE ID, are very
diﬃcult to genotype using only one methodology. Moreover,
in confirmatory PCR a primer inside the Alu sequence is
used, and the two samples not detected by DHPLC could
have amplified other genes to Alu insertion polymorphisms.
Comparing DHPLC and the confirmatory PCR method-
ology used for the same purpose, DHPLC has the advantages
of ease of handling and significantly fewer problems with
data interpretation. Besides its application in ACE I/D
polymorphism, DHPLC is a powerful tool for clinical and
population analysis of InDels in general, which may greatly
increase laboratory throughput.
5. CONCLUSIONS
InDels may be observed as one- or multibase pair expansions
of repeat units, besides random DNA sequences as trans-
poson insertions and deletions and their detection is used
for the purpose of genetic mapping and diagnostics. The
DHPLC method usually can detect small repeat units under
nondenaturating conditions. With the approach described
in the present study, DHPLC can be used to genotype large
InDels, as demonstrated in the detection of ACE gene I/D
polymorphisms. This method could be useful in clinical
applications, and carries the advantage of avoiding possible
gel misinterpretation and, thus, genotype misinterpretations.
In conclusion, the DHPLC design described in this study is
an alternative approach for large InDel detection and could
be used in studies that evaluate this kind of polymorphism.
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